These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3856054)
1. Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase. Kadohama N; Wakisaka M; Kim U; Karr JP; Murphy GP; Sandberg AA J Natl Cancer Inst; 1985 Feb; 74(2):475-86. PubMed ID: 3856054 [TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid. Kadohama N; Karr JP; Murphy GP; Sandberg AA Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158 [TBL] [Abstract][Full Text] [Related]
3. The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate. Wenderoth UK; George FW; Wilson JD Endocrinology; 1983 Aug; 113(2):569-73. PubMed ID: 6872940 [TBL] [Abstract][Full Text] [Related]
4. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors. Liang T; Rasmusson GH; Brooks JR J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of 3 beta-hydroxysteroid-dehydrogenase: an approach for prostate cancer treatment? Geldof AA; Dijkstra I; Newling DW; Rao BR Anticancer Res; 1995; 15(4):1349-54. PubMed ID: 7654020 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707 [TBL] [Abstract][Full Text] [Related]
7. Effect of a new 5 alpha-reductase inhibitor on size, histologic characteristics, and androgen concentrations of the canine prostate. Brooks JR; Berman D; Glitzer MS; Gordon LR; Primka RL; Reynolds GF; Rasmusson GH Prostate; 1982; 3(1):35-44. PubMed ID: 7079196 [TBL] [Abstract][Full Text] [Related]
8. Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor. Brooks JR; Baptista EM; Berman C; Ham EA; Hichens M; Johnston DB; Primka RL; Rasmusson GH; Reynolds GF; Schmitt SM; Arth GE Endocrinology; 1981 Sep; 109(3):830-6. PubMed ID: 7262023 [No Abstract] [Full Text] [Related]
9. Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid. Liang T; Heiss CE J Biol Chem; 1981 Aug; 256(15):7998-8005. PubMed ID: 7263637 [TBL] [Abstract][Full Text] [Related]
11. Consideration of the use of 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5- alpha-androstan-3-one (4MA), a 5 alpha-reductase inhibitor, in prostate cancer therapy. Geldof AA; Meulenbroek MF; Dijkstra I; Bohlken S; Rao BR J Cancer Res Clin Oncol; 1992; 118(1):50-5. PubMed ID: 1729259 [TBL] [Abstract][Full Text] [Related]
12. Effect of a 4-methyl-4-aza steroid on androgen metabolism by rat ventral prostate epithelial and stromal cell cultures: selective inhibition of 5 alpha-reductase activity. Orlowski J; Clark AF Prostate; 1988; 13(4):289-97. PubMed ID: 3217276 [TBL] [Abstract][Full Text] [Related]
13. Inhibition by a 4-methyl-4-aza-steroid of NADPH: delta 4-3-oxosteroid-5 alpha-oxido-reductase activity in cultured interstitial cells derived from immature rat testis. Verhoeven G; Cailleau J J Steroid Biochem; 1983 Mar; 18(3):365-7. PubMed ID: 6857752 [TBL] [Abstract][Full Text] [Related]
14. Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer. Shao TC; Li H; Ittmann M; Cunningham GR J Urol; 2007 Oct; 178(4 Pt 1):1521-7. PubMed ID: 17707058 [TBL] [Abstract][Full Text] [Related]
15. Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes. Liang T; Heiss CE; Ostrove S; Rasmusson GH; Cheung A Endocrinology; 1983 Apr; 112(4):1460-8. PubMed ID: 6832056 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of steroid 5 alpha-reductase from human skin fibroblasts by 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one. Leshin M; Wilson JD J Steroid Biochem; 1982 Sep; 17(3):245-50. PubMed ID: 6957692 [TBL] [Abstract][Full Text] [Related]
17. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate. Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049 [TBL] [Abstract][Full Text] [Related]
18. 5 Alpha-reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the rat. Brooks JR; Berman C; Primka RL; Reynolds GF; Rasmusson GH Steroids; 1986 Jan; 47(1):1-19. PubMed ID: 3810695 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of 5 alpha-reductase activity and alteration of nuclear testosterone. Dihydrotestosterone ratio in human genital skin fibroblasts. Berkovitz GD; Brown TR; Migeon CJ J Androl; 1984; 5(3):171-5. PubMed ID: 6746410 [TBL] [Abstract][Full Text] [Related]
20. Effect of 5-alpha-reductase inhibition and dexamethasone administration on the growth characteristics and intratumor androgen levels of the human prostate cancer cell line PC-3. Tuttle RM; Loop S; Jones RE; Meikle AW; Ostenson RC; Plymate SR Prostate; 1994 May; 24(5):229-36. PubMed ID: 8170835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]